Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Composite Hydrogel Embedded with Porous Microspheres for Long-Term pH-Sensitive Drug Delivery.

Literature DB >> 30152721

Composite Hydrogel Embedded with Porous Microspheres for Long-Term pH-Sensitive Drug Delivery.

Xifeng Liu^1,2, Kevin A Fundora¹, Zifei Zhou¹, Alan Lee Miller², Lichun Lu^1,2.

Abstract

IMPACT STATEMENT: A composite hydrogel embedded with porous microspheres fabricated by phase separation methods was developed and showed excellent long-term anticancer drug delivery capability to cancer cells.

Entities: Disease

Keywords: cancer; drug delivery; hydrogel; osteosarcoma; porous microspheres

Mesh：

Substances：

Year: 2018 PMID： 30152721 PMCID： PMC6388718 DOI： 10.1089/ten.TEA.2018.0071

Source DB: PubMed Journal: Tissue Eng Part A ISSN： 1937-3341 Impact factor: 3.845

34 in total

1. Nanoparticle solutions as adhesives for gels and biological tissues.

Authors: Séverine Rose; Alexandre Prevoteau; Paul Elzière; Dominique Hourdet; Alba Marcellan; Ludwik Leibler
Journal: Nature Date: 2013-12-11 Impact factor: 49.962

Review 2. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.

Authors: Elvira C van Dalen; Erna Mc Michiels; Huib N Caron; Leontien Cm Kremer
Journal: Cochrane Database Syst Rev Date: 2010-05-12

3. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?

Authors: Leo Kager; Christopher Diakos; Stefan Bielack
Journal: Expert Opin Drug Metab Toxicol Date: 2015-04-16 Impact factor: 4.481

Review 4. Doxil®--the first FDA-approved nano-drug: lessons learned.

Authors: Yechezkel Barenholz
Journal: J Control Release Date: 2012-03-29 Impact factor: 9.776

5. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.

Authors: P J O'Dwyer; J Manola; F H Valone; L M Ryan; J D Hines; S Wadler; D G Haller; S G Arbuck; L M Weiner; R J Mayer; A B Benson
Journal: J Clin Oncol Date: 2001-05-01 Impact factor: 44.544

6. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering.

Authors: Johnna S Temenoff; Kyriacos A Athanasiou; Richard G LeBaron; Antonios G Mikos
Journal: J Biomed Mater Res Date: 2002-03-05

Composite Hydrogel Embedded with Porous Microspheres for Long-Term pH-Sensitive Drug Delivery.

1. Nanoparticle solutions as adhesives for gels and biological tissues.

Review 2. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.

3. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?

Review 4. Doxil®--the first FDA-approved nano-drug: lessons learned.

5. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.

6. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering.

Review 7. Drug resistance and the solid tumor microenvironment.

8. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels.

9. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.

10. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

1. 3D bioprinting of oligo(poly[ethylene glycol] fumarate) for bone and nerve tissue engineering.